En los pacientes con infarto agudo de miocardio tratados con reperfusión coronaria percutánea, la administración de media dosis de reteplasa y dosis completa de abciximab se asocia a igual mortalidad a los 30 días que la administración de sólo la dosis completa de reteplasa, aunque puede aumentar el
Administration of reteplase and abciximab, compared with reteplase administration, does not improve mortality in patients with acute myocardial infarction and coronary revascularization
Read
3064
Timeswas read the article
1219
Total PDF
1845
Total HTML
Article information
ISSN: 02105691Original language: Spanish
The statistics are updated each day
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 11 | 193 | 141 | 334 |
| 2025 10 | 5 | 46 | 51 |
| 2025 9 | 0 | 79 | 79 |
| 2025 8 | 0 | 31 | 31 |
| 2025 7 | 0 | 35 | 35 |
| 2025 6 | 5 | 25 | 30 |
| 2025 5 | 346 | 29 | 375 |
| 2025 4 | 100 | 27 | 127 |
| 2025 3 | 94 | 22 | 116 |
| 2025 2 | 117 | 49 | 166 |
| 2025 1 | 63 | 50 | 113 |
| 2024 12 | 60 | 43 | 103 |
| 2024 11 | 38 | 57 | 95 |
| 2024 10 | 43 | 47 | 90 |
| 2024 9 | 61 | 29 | 90 |
| 2024 8 | 56 | 51 | 107 |
| 2024 7 | 53 | 37 | 90 |
| 2024 6 | 46 | 39 | 85 |
| 2024 5 | 45 | 37 | 82 |
| 2024 4 | 29 | 23 | 52 |
| 2024 3 | 48 | 29 | 77 |
| 2024 2 | 83 | 45 | 128 |
| 2024 1 | 48 | 43 | 91 |
| 2023 12 | 77 | 45 | 122 |
| 2023 11 | 44 | 24 | 68 |
| 2023 10 | 47 | 22 | 69 |
| 2023 9 | 46 | 28 | 74 |
| 2023 8 | 35 | 16 | 51 |
| 2023 7 | 35 | 28 | 63 |
| 2023 6 | 18 | 30 | 48 |
| 2023 5 | 10 | 12 | 22 |
Show all
